Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese

Multiple Sclerosis

Volumn 15, Issue 7, 2009, Pages 834-847

  Matsushita, T ^a   Isobe, N ^a   Matsuoka, T ^a   Shi, N ^a   Kawano, Y ^a   Wu, X M ^a   Yoshiura, T ^a   Nakao, Y ^b   Ishizu, T ^a   Kira, J I ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aquaporin 4; Autoantibody; Cytokine; Neuromyelitis optica; Opticospinal multiple sclerosis; Th2

Indexed keywords

AQUAPORIN 4; AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CD4 LYMPHOCYTE PERCENTAGE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELITIS; OPTIC NEURITIS; OPTICOSPINAL MULTIPLE SCLEROSIS; PERIPHERAL LYMPHOCYTE; RECURRENT DISEASE; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

AQUAPORIN 4; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-4; JAPAN; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROMYELITIS OPTICA; OPTIC NEURITIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SPINAL CORD; SYNDROME;

EID: 67649383226     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509104595     Document Type: Article

References (37)

1. Wingerchuk, DM, Hogancamp, WF, O'Brien, PC, Weinshenker, BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-1114.
2. Wingerchuk, DM, Lennon, VA, Pittock, SJ, Lucchinetti, CF, Weinshenker, BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
3. Lennon, VA, Wingerchuk, DM, Kryzer, TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
4. Lennon, VA, Kryzer, TJ, Pittock, SJ, Verkman, AS, Hinson, SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-477.
5. Kira, J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003; 2: 117-127.
6. Kira, J, Kanai, T, Nishimura, Y, et al. Western versus Asian types of multiple sclerosis: Immunogenetically and clinically distinct disorders. Ann Neurol 1996; 40: 569-574.
7. Cree, BAC, Goodin, DS, Hauser, SL. Neuromyelitis optica. Semin Neurol 2002; 22: 105-122.
8. Lucchinetti, CF, Mandler, RN, McGavern, D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-1461.
9. Yamasaki, K, Horiuchi, I, Minohara, M, et al. HLA-DPB1* 0501-associated opticospinal multiple sclerosis: Clinical, neuroimaging and immunogenetic studies. Brain 1999; 122: 1689-1696.
10. Ishizu, T, Osoegawa, M, Mei, F-J, et al. Interathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005; 128: 988-1002.
11. Nakashima, I, Fujihara, K, Miyazawa, I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006; 77: 1073-1075.
12. Weinshenker, BG, Wingerchuk, DM, Nakashima, I, Fujihara, K, Lennon, VA. OSMS is NMO, but not MS: Proven clinically and pathologically. Lancet Neurol 2006; 5: 110-111.
13. Takahashi, T, Fujihara, K, Nakashima, I, et al. Antiaquaporin-4 antibody is involved in the pathogenesis of NMO: A study on antibody titre. Brain 2007; 130: 1235-1243.
14. Misu, T, Fujihara, K, Kakita, A, et al. Loss of aquaporin-4 in lesions of neuromyelitis optica: Distinction from multiple sclerosis. Brain 2007; 130: 1224-1234.
15. Romer, SF, Parisi, JE, Lennon, VA, et al. Pattern-specific neuromyelitis optica from multiple sclerosis. Brain 2007; 130: 1194-1205.
16. Jacob, A, Matiello, M, Wingerchuk, DM, Lucchinetti, CF, Pittock, SJ, Weinshenker, BG. Neuromyelitis optica: Changing concepts. J Neuroimmunol 2007; 187: 126-138.
17. Horowitz, AL, Kaplan, RD, Grewe, G, White, RT, Salberg, LM. The ovoid lesion: A new MR observation in patients with multiple sclerosis. Am J Neuroradiol 1989; 10: 303-305.
18. Matsuoka, T, Matsushita, T, Kawano, Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007; 130: 1206-1223.
19. Chong, HT, Ramli, N, Lee, KH, et al. Magnetic resonance imaging of Asians with multiple sclerosis was similar to that of the West. Neurol Asia 2004; 9: 47-53.
20. Minohara, M, Matsuoka, T, Li, W, et al. Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: Positive correlation with disease severity. J Neuroimmunol 2006; 178: 156-160.
21. Su, J-J, Osoegawa, M, Minohara, M, et al. Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings. J Neurol Sci 2006; 243: 21-30.
22. Matsuoka, T, Matsushita, T, Osoegawa, M, et al. Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings. J Neurol Sci 2008; 266: 115-125.
23. Bot, JCJ, Barkhof, F, Polman, CH, et al. Spinal cord abnormalities in recently diagnosed MS patients: Added value of spinal MRI examination. Neurology 2004; 62: 226-233.
24. Tanaka, K, Tani, T, Tanaka, M, et al. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 2007; 13: 850-855.
25. Saida, T, Tashiro, K, Itoyama, Y, et al. Interferon beta-1b is effective in Japanese RRMS patients. A randomized, multicenter study. Neurology 2005; 64: 621-630.
26. Poser, CM, Paty, DW, Scheinberg, L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
27. Kurtzke, JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
28. Fukazawa, T, Hamada, T, Tashiro, K, Moriwaka, F, Yanagihara, T. Acute transverse myelopathy in multiple sclerosis. J Neurol Sci 1990; 100: 217-222.
29. Barkhof, F, Filippi, M, Miller, DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-2069.
30. Pittock, SJ, Lennon, VA, Krecke, K, Wingerchuk, DM, Lucchinetti, CF, Weinshenker, BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63: 390-396.
31. Kira, J, Kawano, Y, Yamasaki, K, Tobimatsu, S. Acute myelitis with hyperIgEaemia and mite antigen specific IgE: Atopic myelitis. J Neurol Neurosurg Psychiatry 1998; 64: 676-679.
32. Paty, DW, Oger, JJ, Kastrukoff, LF, et al. MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988; 38: 180-185.
33. Ochi, H, Mei, F-J, Osoegawa, M, et al. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b. J Neurol Sci 2004; 222: 65-73.
34. Polman, CH, Reingold, SC, Edan, G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005; 58: 840-846.
35. Osoegawa, M, Kira, J, Fukazawa, T, et al. Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler 2009; 15: 159-173.
36. Sueoka, E, Yukitake, M, Iwanaga, K, Sueoka, N, Aihara, T, Kuroda, Y. Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patients. Ann Neurol 2004; 56: 778-786.
37. Mathey, EK, Derfuss, T, Storch, MK, et al. Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med 2007; 204: 2363-2372.